23Oct
06Oct
Corbus Awarded US Patent Covering Lenabasum as Potential CF and Fibrotic Disease Treatment
Corbus Pharmaceuticals has received a patent from the U.S. Patent and Trademark Office covering all compositions that comprise lenabasum and might be used to treat any fibrotic disease, including cystic fibrosis (CF), the company announced in a press release. Read more >>
05Oct
When product development goes sideways (and how to fix it)
Product development going wrong? You may need a tiger team. By Jeff Champagne and Eric Claude, MPR Associates, Inc. We would all like for product development projects to go smoothly and predictably, but you know what they say about “the best-laid plans.” Robert Burns aside, when needed technologies do not integrate as easily as planned, hardware or software bugs crop up at the last minute (or worse, cause failures in the field), or project teams struggle to complete work on schedule, forward...
05Oct
Smart Health Innovation Lab Announces Graduates of Certification Program’s Inaugural Class
Smart Health Innovation Lab, a market adoption accelerator for healthcare technologies, today announced the graduation of two companies — Emovi and NeuroFlow – from its Smart Health Certification Program’s inaugural class of 2018. Read more >>
05Oct
Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards
Massachusetts’ largest technology trade association announced the winners of the region’s most prestigious technology awards at their 21st annual Mass Technology Leadership Awards Gala at Boston’s Seaport World Trade Center. Hundreds gathered to celebrate the people and companies shaping the Massachusetts technology economy in 15 categories—including Massachusetts Company of the Year, CarGurus; Emerging Massachusetts Company of the Year, Flywire; and CEO of the Year, Carbonite’s Mohamad Ali. Read more >>
03Oct
Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform
Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, and Scaled Biolabs (Scaled) announced the two firms are collaborating to optimize PBG’s unique production process for making human platelets, or PLTs+™. The agreement was announced at the SynBioBeta 2018 biology summit. Read more >>
02Oct
Western New York Impact Investing Fund backs recycled insulation startup Cleanfiber
The Western New York Impact Investment Fund has backed Cleanfiber to add a new production facility and create dozens of jobs in… Western New York. Read more >>
02Oct
43North winner raises $4.9 million to advance plans for local factory
CleanFiber has raised $4.9 million in private financing as it enacts plans to open a full-fledged factory in Western New York in the next few months. Read more >>
27Sep
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in October
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its industry leading pipeline of endocannabinoid system-targeting drug candidates, announced today that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming investor conferences in October. Read more >>
25Sep